N-acetylcysteine normalizes neurochemical changes in the glutathione-deficient schizophrenia mouse model during development

Introduction to Linear Regression Analysis.

Assunção, R., Sampson, P. D., Montgomery, D. C., & Peck, E. A. (1993) · Journal of the American Statistical Association · doi:10.2307/2290746 · Cited by 5,389 · see citing works

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses

Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330 · see citing works

NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons

Homayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231 · see citing works

Schizophrenia as a Disorder of Neurodevelopment

Lewis, D. A., & Levitt, P. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142754 · Cited by 1,163 · see citing works

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

Patil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., Avedisova, A. S., Bardenstein, L. M., Gurovich, I. Y., Morozova, M. A., et al. (2007) · Nature Medicine · doi:10.1038/nm1632 · Cited by 1,040 · see citing works

Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress

Prabakaran, S., SWATTON, J. E., Ryan, M. M., Huffaker, S. J., Huang, J.-J., Griffin, J. L., Wayland, M. T., Freeman, T., Dudbridge, F., Lilley, K. S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001511 · Cited by 973 · see citing works

Automatic, localized in Vivo adjustment of all first‐and second‐order shim coils

Gruetter, R. (1993) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910290613 · Cited by 875 · see citing works

N-Acetylcysteine—a safe antidote for cysteine/glutathione deficiency

Atkuri, K. R., Mantovani, J. J., Herzenberg, L. A., & Herzenberg, L. A. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.04.005 · Cited by 721 · see citing works

Neuroinflammation, Oxidative Stress and the Pathogenesis of Alzheimers Disease

Agostinho, P., A. Cunha, R., & Oliveira, C. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210793176572 · Cited by 685 · cited 1× · see citing works

Food Intake, Water Intake, and Drinking Spout Side Preference of 28 Mouse Strains

Bachmanov, A. A., Reed, D. R., Beauchamp, G. K., & Tordoff, M. G. (2002) · Behavior Genetics · doi:10.1023/a:1020884312053 · Cited by 679 · see citing works

Ontogeny of the human central nervous system: What is happening when?

de Graaf-Peters, V. B., & Hadders-Algra, M. (2006) · Early Human Development · doi:10.1016/j.earlhumdev.2005.10.013 · Cited by 559 · see citing works

N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial

Berk, M., Copolov, D., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Judd, F., Katz, F., Katz, P., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.004 · Cited by 552 · see citing works

Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo

Do, K. Q., Trabesinger, A. H., Kirsten‐Krüger, M., Lauer, C. J., Dydak, U., Hell, D., Holsboer, F., Boesiger, P., & Cuénod, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00229.x · Cited by 540 · see citing works

Alterations in Brain High-Energy Phosphate and Membrane Phospholipid Metabolism in First-Episode, Drug-Naive Schizophrenics

Pettegrew, J. W. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810300075011 · Cited by 482 · see citing works

Toward an in Vivo Neurochemical Profile: Quantification of 18 Metabolites in Short-Echo-Time 1H NMR Spectra of the Rat Brain

Pfeuffer, J., Tkáč, I., Provencher, S. W., & Rolf Gruetter, A. (1999) · Journal of Magnetic Resonance · doi:10.1006/jmre.1999.1895 · Cited by 471 · see citing works

The antioxidants α‐lipoic acid and <i>N</i> ‐acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice

Farr, S. A., Poon, H. F., Dogrukol‐Ak, D., Drake, J., Banks, W. A., Eyerman, E., Butterfield, D. A., & Morley, J. E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01580.x · Cited by 459 · see citing works

Taurine: new implications for an old amino acid

Schuller‐Levis, G., & Park, E. (2003) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00611-6 · Cited by 425 · see citing works

Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell

Smith, J., Ladi, E., Mayer-Pröschel, M., & Noble, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170209797 · Cited by 399 · see citing works

N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?

Kantrowitz, J. T., & Javitt, D. C. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.04.006 · Cited by 397 · see citing works

Redox dysregulation, neurodevelopment, and schizophrenia

Do, K. Q., Cabungcal, J. H., Frank, A., Steullet, P., & Cuenod, M. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.05.001 · Cited by 384 · see citing works

Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress

Prabakaran, S., SWATTON, J. E., Ryan, M. M., Huffaker, S. J., Huang, J. T.-J., Griffin, J. L., Wayland, M. T., Freeman, T., Dudbridge, F., Lilley, K. S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001532 · Cited by 375 · see citing works

Glutathione Precursor, N-Acetyl-Cysteine, Improves Mismatch Negativity in Schizophrenia Patients

Lavoie, S., Murray, M. M., Deppen, P., Knyazeva, M. G., Berk, M., Boulat, O., Bovet, P., Bush, A. I., Conus, P., Copolov, D., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301624 · Cited by 371 · see citing works

MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T

Ralf Mekle, A., Mlynárik, V., Gambarota, G., Hergt, M., Krüger, G., & Rolf Gruetter, A. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21961 · Cited by 328 · see citing works

Altered glutathione redox state in schizophrenia.

Yao, J. K., Leonard, S., & Reddy, R. (2006) · Disease Markers · doi:10.1155/2006/248387 · Cited by 321 · see citing works

Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence

Gysin, R., Kraftsik, R., Sandell, J., Bovet, P., Chappuis, C., Conus, P., Deppen, P., Preisig, M., Ruiz, V., Steullet, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706778104 · Cited by 309 · see citing works

Functional and Dysfunctional Synaptic Plasticity in Prefrontal Cortex: Roles in Psychiatric Disorders

Goto, Y., Yang, C. R., & Otani, S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.026 · Cited by 305 · see citing works

Metabolic Profiling of CSF: Evidence That Early Intervention May Impact on Disease Progression and Outcome in Schizophrenia

Holmes, E. C., Tsang, T. M., Huang, J. T.-J., Leweke, F. M., Koethe, D., Gerth, C. W., Nolden, B. M., Gross, S., Schreiber, D., Nicholson, J. K., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030327 · Cited by 292 · see citing works

Localized short‐echo‐time proton MR spectroscopy with full signal‐intensity acquisition

Mlynárik, V., Gambarota, G., Hanne Frenkel, A., & Rolf Gruetter, A. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21043 · Cited by 275 · see citing works

System xc− and Thioredoxin Reductase 1 Cooperatively Rescue Glutathione Deficiency

Mandal, P. K., Seiler, A., Perisic, T., Kölle, P., Banjac Canak, A., Förster, H., Weiss, N., Kremmer, E., Lieberman, M. W., Bannai, S., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.121327 · Cited by 269 · see citing works

Initial Characterization of the Glutamate-Cysteine Ligase Modifier Subunit Gclm(−/−) Knockout Mouse

Yang, Y., Dieter, M. Z., Chen, Y., Shertzer, H. G., Nebert, D. W., & Dalton, T. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209372200 · Cited by 269 · see citing works

Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis

Steen, R. G., Hamer, R. M., & Lieberman, J. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300850 · Cited by 254 · see citing works

Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode Psychosis

de la Fuente-Sandoval, C., León-Ortíz, P., Favila, R., Stephano, S., Mamo, D., Ramírez-Bermúdez, J., & Graff-Guerrero, A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.65 · Cited by 248 · see citing works

Schizophrenia and Oxidative Stress: Glutamate Cysteine Ligase Modifier as a Susceptibility Gene

Tosic, M., Ott, J., Barral, S., Bovet, P., Deppen, P., Gheorghita, F., Matthey, M.-L., Parnas, J., Preisig, M., Saraga, M., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/507566 · Cited by 234 · see citing works

Redox Dysregulation Affects the Ventral But Not Dorsal Hippocampus: Impairment of Parvalbumin Neurons, Gamma Oscillations, and Related Behaviors

Steullet, P., Cabungcal, J.-H., Kulak, A., Kraftsik, R., Chen, Y., Dalton, T. P., Cuenod, M., & Do, K. Q. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3857-09.2010 · Cited by 202 · see citing works

Introduction to Linear Regression Analysis

Karlsson, A. (2007) · Journal of the Royal Statistical Society Series A (Statistics in Society) · doi:10.1111/j.1467-985x.2007.00485_6.x · Cited by 197 · see citing works

Relationships among Brain Metabolites, Cognitive Function, and Viral Loads in Antiretroviral-Naıve HIV Patients

Chang, L., Ernst, T., Witt, M. D., Ames, N., Gaiefsky, M., & Miller, E. N. (2002) · NeuroImage · doi:10.1006/nimg.2002.1254 · Cited by 190 · see citing works

Assignment of the water slow-diffusing component in the central nervous system using q-space diffusion MRS: Implications for fiber tract imaging

Assaf, Y., & Cohen, Y. (2000) · Magnetic Resonance in Medicine · doi:10.1002/(sici)1522-2594(200002)43:2 · Cited by 184 · see citing works

Elevated Cerebrospinal Fluid Lactate Concentrations in Patients with Bipolar Disorder and Schizophrenia: Implications for the Mitochondrial Dysfunction Hypothesis

Regenold, W. T., Phatak, P., Marano, C. M., Sassan, A., Conley, R. R., & Kling, M. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.010 · Cited by 171 · see citing works

[3] Glutathione biosynthesis and its inhibition

Meister, A. (1995) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(95)52005-8 · Cited by 171 · see citing works

α-Ketoglutarate dehydrogenase: A mitochondrial redox sensor

McLain, A. L., Szweda, P. A., & Szweda, L. I. (2010) · Free Radical Research · doi:10.3109/10715762.2010.534163 · Cited by 170 · see citing works

Parkinson's disease: insights from pathways

Cookson, M., & Bandmann, O. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq167 · Cited by 162 · see citing works

1H-MRS at 4 Tesla in minimally treated early schizophrenia

Bustillo, J. R., Rowland, L. M., Mullins, P., Jung, R., Chen, H., Qualls, C., Hammond, R., Brooks, W. M., & Lauriello, J. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.121 · Cited by 153 · see citing works

3-T Proton MRS Investigation of Glutamate and Glutamine in Adolescents at High Genetic Risk for Schizophrenia

Tibbo, P. G., Hanstock, C. C., Valiakalayil, A., & Allen, P. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1116 · Cited by 152 · see citing works

Childhood onset schizophrenia: support for a progressive neurodevelopmental disorder

Rapoport, J. L., & Gogtay, N. (2010) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.10.003 · Cited by 132 · see citing works

Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging

Parnetti, L., Tarducci, R., Presciutti, O., Lowenthal, D. T., Pippi, M., Palumbo, B., Gobbi, G., Pelliccioli, G. P., & Senin, U. (1997) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(97)01877-0 · Cited by 130 · see citing works

Proton MRS in twin pairs discordant for schizophrenia

Lutkenhoff, E. S., van Erp, T. G., Thomas, M. A., Therman, S., Manninen, M., HUTTUNEN, M. O., Kaprio, J. A., Lönnqvist, J. K., O’Neill, J., & Cannon, T. D. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.87 · Cited by 127 · see citing works

Role of oxidative stress in the pathophysiology of bipolar disorder

Steckert, A. V., Valvassori, S. S., Moretti, M., Dal‐Pizzol, F., & Quevedo, J. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0195-2 · Cited by 125 · see citing works

Late <i>N</i>‐acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation

Lanté, F., Meunier, J., Guiramand, J., De Jesus Ferreira, M., Cambonie, G., Aimar, R., Cohen‐Solal, C., Maurice, T., Vignes, M., & Barbanel, G. (2008) · Hippocampus · doi:10.1002/hipo.20421 · Cited by 124 · see citing works

Thinking Glutamatergically: Changing Concepts of Schizophrenia Based Upon Changing Neurochemical Models

Kantrowitz, J. T., & Javitt, D. C. (2010) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.4.3.6 · Cited by 118 · see citing works

Parameters related to lipid metabolism as markers of myelination in mouse brain

Muse, E. D., Jurevics, H. A., Toews, A. D., Matsushima, G. K., & Morell, P. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00015.x · Cited by 116 · see citing works

Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS)

Tayoshi, S., Sumitani, S., Taniguchi, K., Shibuya‐Tayoshi, S., Numata, S., Iga, J., Nakataki, M., Ueno, S., Harada, M., & Ohmori, T. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.11.014 · Cited by 111 · see citing works

Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients

Hashimoto, K., Engberg, G., Shimizu, E., Nordin, C., Lindström, L., & Iyo, M. (2005) · BMC Psychiatry · doi:10.1186/1471-244x-5-6 · Cited by 106 · see citing works

Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study

Ohrmann, P., Siegmund, A., Suslow, T., Spitzberg, K., Kersting, A., Arolt, V., Heindel, W. L., & Pfleiderer, B. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.08.021 · Cited by 100 · see citing works

Correlations between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites

Yao, J. K., Stanley, J. A., Reddy, R. D., Keshavan, M. S., & Pettegrew, J. W. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01397-5 · Cited by 100 · see citing works

Correlation of Regional Proton Magnetic Resonance Spectroscopic Metabolic Changes With Cognitive Deficits in Mild Alzheimer Disease

Chantal, S., Labelle, M., Bouchard, R. W., Braun, C. M. J., & Boulanger, Y. (2002) · Archives of Neurology · doi:10.1001/archneur.59.6.955 · Cited by 95 · see citing works

Glutamate as a Marker of Cognitive Function in Schizophrenia: A Proton Spectroscopic Imaging Study at 4 Tesla

Bustillo, J., Chen, H., Gasparovic, C., Mullins, P. G., Caprihan, A., Qualls, C., Apfeldorf, W. J., Lauriello, J., & Posse, S. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.024 · Cited by 94 · see citing works

Increased lactate levels and reduced pH in postmortem brains of schizophrenics: Medication confounds

Halim, N. D., Lipska, B. K., Hyde, T. M., Deep‐Soboslay, A., Saylor, E., Herman, M. M., Thakar, J. H., Verma, A. M., & Kleinman, J. E. (2007) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2007.11.017 · Cited by 91 · see citing works

Linking white and grey matter in schizophrenia: Oligodendrocyte and neuron pathology in the prefrontal cortex

Höistad, M. (2009) · Frontiers in Neuroanatomy · doi:10.3389/neuro.05.009.2009 · Cited by 87 · see citing works

Neurochemical changes in the rat prefrontal cortex following acute phencyclidine treatment: an in vivo localized 1H MRS study

Iltis, I., Koski, D. M., Eberly, L. E., Nelson, C. D., Deelchand, D. K., Valette, J., Uǧurbil, K., Lim, K. O., & Henry, P. (2009) · NMR in Biomedicine · doi:10.1002/nbm.1385 · Cited by 83 · see citing works

Magnetic Resonance Spectroscopy Study of the Antioxidant Defense System in Schizophrenia

Matsuzawa, D., & Hashimoto, K. (2011) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2010.3453 · Cited by 79 · see citing works

Glutamate, a neurotransmitter—And so much more

Hertz, L. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2005.12.021 · Cited by 78 · see citing works

Oxidative Stress in Schizophrenia: Pathogenetic and Therapeutic Implications

Yao, J. K., & Reddy, R. D. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3646 · Cited by 76 · see citing works

Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: Investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus

Yoo, S. Y., Yeon, S., Choi, C., Kang, D.-H., Lee, J., Shin, N. Y., Jung, W. H., Choi, J., Jang, D., & Kwon, J. S. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.036 · Cited by 76 · see citing works

Metabolic abnormalities in fronto-striatal-thalamic white matter tracts in schizophrenia

Beasley, C. L., Dwork, A. J., Rosoklija, G. B., Mann, J. J., Mancevski, B., Jakovski, Z., Davceva, N., Tait, A. R., Straus, S. K., & Honer, W. G. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.01.017 · Cited by 62 · see citing works

Biosynthesis of brain sphingolipids and myelin accumulation in the mouse

Costantino‐Ceccarini, E., & Morell, P. (1972) · Lipids · doi:10.1007/bf02533072 · Cited by 59 · see citing works

Striatal metabolic alterations in non-psychotic adolescent offspring at risk for schizophrenia: A 1H spectroscopy study

Keshavan, M. S., Dick, R. M., Diwadkar, V. A., Montrose, D. M., Prasad, K. M. R., & Stanley, J. A. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.08.012 · Cited by 59 · see citing works

Aspartoacylase is restricted primarily to myelin synthesizing cells in the CNS: therapeutic implications for Canavan disease

Kirmani, B. F., Jacobowitz, D. M., Kallarakal, A. T., & Namboodiri, M. A. A. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00490-4 · Cited by 59 · see citing works

Neurochemical profile of the developing mouse cortex determined by in vivo1H NMR spectroscopy at 14.1 T and the effect of recurrent anaesthesia

Kulak, A., Duarte, J. M. N., Kim, Q., & Rolf Gruetter, A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07051.x · Cited by 56 · see citing works

Birth-related genomic and transcriptional changes in mouse lung

Izzotti, A., Balansky, R. M., Camoirano, A., Cartiglia, C., Longobardi, M., Tampa, E., & Flora, S. D. (2003) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2003.05.004 · Cited by 51 · see citing works

In vivo measurement of glycine with short echo-time 1H MRS in human brain at 7 T

Gambarota, G., Ralf Mekle, A., Xin, L., Hergt, M., van der Zwaag, W., Krüger, G., & Rolf Gruetter, A. (2008) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-008-0152-0 · Cited by 47 · see citing works

Mitochondrial matters of the brain: the role in Huntington’s disease

Turner, C., & Schapira, A. H. V. (2010) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-010-9290-y · Cited by 44 · see citing works

Protection by pyruvate against glutamate neurotoxicity is mediated by astrocytes through a glutathione-dependent mechanism

Miao, Y., Qiu, Y., Lin, Y., Miao, Z., Zhang, J., & Lu, X. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-9998-0 · Cited by 39 · see citing works

Interaction of hippocampal volume and N-acetylaspartate concentration deficits in schizophrenia: A combined MRI and 1H-MRS study

Klär, A. A., Ballmaier, M., Leopold, K., Häke, I., Schaefer, M., Brühl, R., Schubert, F., & Gallinat, J. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.06.006 · Cited by 37 · see citing works

Comparison of brain N-acetylaspartate levels and serum brain-derived neurotrophic factor (BDNF) levels between patients with first-episode schizophrenia psychosis and healthy controls

Gotō, N., Yoshimura, R., Kakeda, S., Moriya, J., Hayashi, K., Ikenouchi, A., Umene‐Nakano, W., Hori, H., Ueda, N., Korogi, Y., et al. (2010) · European Psychiatry · doi:10.1016/j.eurpsy.2009.10.001 · Cited by 28 · see citing works

Plasma alanine levels increase in patients with schizophrenia as their clinical symptoms improve—Results from the Juntendo University Schizophrenia Projects (JUSP)

Hatano, T., Ohnuma, T., Sakai, Y., Shibata, N., Maeshima, H., Hanzawa, R., Suzuki, T., & Arai, H. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.02.014 · Cited by 26 · see citing works

Capitalizing on Extrasynaptic Glutamate Neurotransmission to Treat Antipsychotic-Resistant Symptoms in Schizophrenia

Krystal, J. H. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.06.011 · Cited by 22 · see citing works

Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology?

Steullet, P., Cabungcal, J. H., Monin, A., Dwir, D., O'Donnell, P., Cuenod, M., & Do, K. Q. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2014.06.021 · Cited by 262 · see citing works

Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism

Smaga, I., Niedzielska, E., Gawlik, M., Moniczewski, A., Krzek, J., Przegaliński, E., Pera, J., & Filip, M. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.12.015 · Cited by 252 · see citing works

Early-Life Insults Impair Parvalbumin Interneurons via Oxidative Stress: Reversal by N-Acetylcysteine

Cabungcal, J.-H., Steullet, P., Kraftsik, R., Cuenod, M., & Do, K. Q. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.020 · Cited by 232 · see citing works

The neurochemical profile quantified by in vivo 1H NMR spectroscopy

Duarte, J. M. N., Lei, H., Mlynárik, V., & Rolf Gruetter, A. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.12.038 · Cited by 222 · see citing works

Imaging glutamate in schizophrenia: review of findings and implications for drug discovery

Poels, E. M. P., Kegeles, L. S., Kantrowitz, J. T., Slifstein, M., Javitt, D. C., Lieberman, J. A., Abi-Dargham, A., & Girgis, R. R. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.136 · Cited by 205 · see citing works

Juvenile Antioxidant Treatment Prevents Adult Deficits in a Developmental Model of Schizophrenia

Cabungcal, J.-H., Counotte, D. S., Lewis, E. M., Tejeda, H. A., Piantadosi, P., Pollock, C., Calhoon, G. G., Sullivan, E. M., Presgraves, E., Kil, J., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.07.028 · Cited by 204 · see citing works

Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia

Maas, D. A., Vallès, A., & Martens, G. J. M. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.138 · Cited by 181 · see citing works

Oxidative stress and schizophrenia

Emiliani, F. E., Sedlak, T. W., & Sawa, A. (2014) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000054 · Cited by 168 · see citing works

Mitochondrial Dysfunction Leads to Cortical Under-Connectivity and Cognitive Impairment

Fernandez, A., Meechan, D. W., Karpinski, B. A., Paronett, E. M., Bryan, C. A., Rutz, H. L. H., Radin, E. A., Lubin, N., Bonner, E. R., Popratiloff, A. S., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.04.013 · Cited by 162 · see citing works

N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis

Conus, P., Seidman, L. J., Fournier, M., Xin, L., Cleusix, M., Baumann, P., Ferrari, C., Cousins, A., Alameda, L., Gholam‐Rezaee, M., et al. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx093 · Cited by 163 · see citing works

Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia

Zhang, Y., Hodgson, N., Trivedi, M. S., Abdolmaleky, H. M., Fournier, M., Cuénod, M., Kim, Q., & Deth, R. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146797 · Cited by 164 · see citing works

Elevated brain lactate in schizophrenia: a 7 T magnetic resonance spectroscopy study

Rowland, L. M., Pradhan, S., Korenic, S. A., Wijtenburg, S. A., Hong, L. E., Edden, R. A. E., & Barker, P. B. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.239 · Cited by 160 · see citing works

Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia

Do, K. Q., Cuenod, M., & Hensch, T. K. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv065 · Cited by 158 · see citing works

The glutathione cycle shapes synaptic glutamate activity

Sedlak, T., Paul, B., Parker, G. M., Hester, L., Snowman, A., Taniguchi, Y., Kamiya, A., Snyder, S., & Sawa, A. (2018) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1817885116 · Cited by 141 · see citing works

Oxidative Stress and the Pathophysiology and Symptom Profile of Schizophrenia Spectrum Disorders

Murray, A., Rogers, J. C., Katshu, M. Z. U. H., Liddle, P. F., & Upthegrove, R. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.703452 · Cited by 147 · see citing works

Decreased Brain pH as a Shared Endophenotype of Psychiatric Disorders

Hagihara, H., Catts, V. S., Katayama, Y., Shoji, H., Takagi, T., Huang, F. L., Nakao, A., Mori, Y., Huang, K., Ishii, S., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.167 · Cited by 143 · see citing works

MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients

Dwir, D., Giangreco, B., Xin, L., Tenenbaum, L., Cabungcal, J.-H., Steullet, P., Goupil, A., Cleusix, M., Jenni, R., Chtarto, A., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0393-5 · Cited by 137 · see citing works

Redox Dysregulation in the Pathophysiology of Schizophrenia and Bipolar Disorder: Insights from Animal Models

Kulak, A., Steullet, P., Cabungcal, J.-H., Werge, T., Ingason, A., Cuenod, M., & Do, K. Q. (2013) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2012.4858 · Cited by 124 · see citing works

Targeting of NMDA receptors in new treatments for schizophrenia

Hashimoto, K. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.934225 · Cited by 115 · see citing works

Antioxidant defense in schizophrenia and bipolar disorder: A meta-analysis of MRS studies of anterior cingulate glutathione

Das, T. K., Javadzadeh, A., Dey, A., Sabesan, P., Théberge, J., Raduà, J., & Palaniyappan, L. K. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.08.006 · Cited by 114 · see citing works

Longitudinal neurochemical modifications in the aging mouse brain measured in vivo by 1H magnetic resonance spectroscopy

Duarte, J. M. N., Kim, Q., & Rolf Gruetter, A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.135 · Cited by 108 · see citing works

Efficacy of N-Acetyl Cysteine in Traumatic Brain Injury

Eakin, K. C., Baratz-Goldstein, R., Pick, C. G., Zindel, O., Balaban, C. D., Hoffer, M. E., Lockwood, M. M., Miller, J. P., & Hoffer, B. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090617 · Cited by 105 · see citing works

Potential Roles of Redox Dysregulation in the Development of Schizophrenia

Perkins, D. O., Jeffries, C. D., & Do, K. Q. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.03.016 · Cited by 103 · see citing works

Taurine Supplementation as a Neuroprotective Strategy upon Brain Dysfunction in Metabolic Syndrome and Diabetes

Rafiee, Z., García-Serrano, A. M., & Duarte, J. M. N. (2022) · Nutrients · doi:10.3390/nu14061292 · Cited by 100 · see citing works

A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia

Bentsen, H., Osnes, K., Refsum, H., Solberg, D. K., & Bøhmer, T. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.110 · Cited by 97 · see citing works

Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry

Nucifora, L. G., Tanaka, T., Hayes, L. N., Kim, M., Lee, B. J., Matsuda, T., Nucifora, F. C., Sedlak, T. W., Mojtabai, R., Eaton, W. W., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.178 · Cited by 94 · see citing works

Behavioral phenotyping of glutathione-deficient mice: Relevance to schizophrenia and bipolar disorder

Kulak, A., Cuenod, M., & Do, K. Q. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.10.020 · Cited by 90 · see citing works

Handling Macromolecule Signals in the Quantification of the Neurochemical Profile

Cudalbu, C., Mlynárik, V., & Rolf Gruetter, A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120100 · Cited by 83 · see citing works

Oxidative Stress in Schizophrenia: Pathogenetic and Therapeutic Implications

Yao, J. K., & Reddy, R. D. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3646 · Cited by 76 · see citing works

Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia

Zugno, A. I., Chipindo, H. L., Volpato, A. M., Budni, J., Steckert, A. V., de Oliveira, M. B., Heylmann, A. S., Silveira, F. D. R., Mastella, G. A., Maravai, S. G., et al. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.11.049 · Cited by 74 · see citing works

N‐acetylcysteine as a new prominent approach for treating psychiatric disorders

Smaga, I., Frankowska, M., & Filip, M. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15456 · Cited by 73 · see citing works

Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism

Duarte, J. M. N., & Xin, L. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2521-z · Cited by 69 · see citing works

Use of proton magnetic resonance spectroscopy in the treatment of psychiatric disorders: a critical update

Bustillo, J. (2013) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2013.15.3/jbustillo · Cited by 60 · see citing works

Potential role of N-acetylcysteine on chlorpyrifos-induced neurotoxicity in rats

Mahmoud, S., Moneim, A. E. A., Qayed, M. M., & El-Yamany, N. A. (2019) · Environmental Science and Pollution Research · doi:10.1007/s11356-019-05366-w · Cited by 54 · see citing works

Putative neuroprotective pharmacotherapies to target the staged progression of mental illness

Robertson, O. D., Coronado, N. G., Sethi, R., Berk, M., & Dodd, S. (2019) · Early Intervention in Psychiatry · doi:10.1111/eip.12775 · Cited by 52 · see citing works

Evaluation of neuron-glia integrity by in vivo proton magnetic resonance spectroscopy: Implications for psychiatric disorders

Xu, H., Zhang, H., Zhang, J., Huang, Q., Shen, Z., & Wu, R. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.09.027 · Cited by 51 · see citing works

Antioxidant Potential of Psychotropic Drugs: From Clinical Evidence to In Vitro and In Vivo Assessment and toward a New Challenge for in Silico Molecular Design

Ribaudo, G., Bortoli, M., Pavan, C., Zagotto, G., & Orian, L. (2020) · Antioxidants · doi:10.3390/antiox9080714 · Cited by 51 · see citing works

Effects of lithium on oxidative stress and behavioral alterations induced by lisdexamfetamine dimesylate: Relevance as an animal model of mania

Macêdo, D. S., de Lucena, D. F., Queiroz, A. I. G., Cordeiro, R. C., Araújo, M. M., Sousa, F. C., Vasconcelos, S. M., Hyphantis, T. N., Quevedo, J., McIntyre, R. S., et al. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.01.007 · Cited by 50 · see citing works

Hippocampal Hyperactivity as a Druggable Circuit-Level Origin of Aberrant Salience in Schizophrenia

Kätzel, D., Wolff, A. R., Bygrave, A. M., & Bannerman, D. M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.486811 · Cited by 50 · see citing works

Antioxidant, histopathological and biochemical outcomes of short-term exposure to acetamiprid in liver and brain of rat: The protective role of N-acetylcysteine and S-methylcysteine

Khovarnagh, N., & Seyedalipour, B. (2021) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2021.02.004 · Cited by 47 · see citing works

Decreased Brain pH and Pathophysiology in Schizophrenia

Park, H. J., Choi, I., & Leem, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168358 · Cited by 46 · see citing works

The GLP-1 receptor agonist liraglutide reverses mania-like alterations and memory deficits induced by D-amphetamine and augments lithium effects in mice: Relevance for bipolar disorder

Filho, A. J. M. C., Cunha, N. L., de Souza, A. G., Soares, M. V.-R., Jucá, P. M., de Queiroz, T., Oliveira, J. V. S., Valvassori, S. S., Barichello, T., Quevedo, J., et al. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109872 · Cited by 44 · see citing works

Thalamic reticular nucleus impairments and abnormal prefrontal control of dopamine system in a developmental model of schizophrenia: prevention by N-acetylcysteine

Zhu, X., Cabungcal, J.-H., Cuénod, M., Uliana, D. L., Kim, Q., & Grace, A. A. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01198-8 · Cited by 44 · see citing works

Neurodevelopmental signatures of narcotic and neuropsychiatric risk factors in 3D human-derived forebrain organoids

Notaras, M. J., Lodhi, A., Barrio-Alonso, E., Foord, C., Rodrick, T. C., Jones, D. R., Fang, H., Greening, D. W., & Colak, D. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01189-9 · Cited by 44 · see citing works

Protective Potential of the Glutathione Peroxidase-1 Gene in Abnormal Behaviors Induced by Phencyclidine in Mice

Tran, T.-V., Shin, E., Jeong, J. H., Lee, J., Lee, Y., Jang, C., Nah, S.-Y., Lei, X. G., Toriumi, K., Yamada, K., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0239-y · Cited by 42 · see citing works

A lack of GluN2A-containing NMDA receptors confers a vulnerability to redox dysregulation: Consequences on parvalbumin interneurons, and their perineuronal nets

Cardis, R., Cabungcal, J.-H., Dwir, D., Kim, Q., & Steullet, P. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.10.006 · Cited by 42 · see citing works

Glutathione Deficit Affects the Integrity and Function of the Fimbria/Fornix and Anterior Commissure in Mice: Relevance for Schizophrenia

Corcoba, A., Steullet, P., Duarte, J. M. N., van de Looij, Y., Monin, A., Cuénod, M., Rolf Gruetter, A., & Kim, Q. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv110 · Cited by 40 · see citing works

Treatment in early psychosis with N-acetyl-cysteine for 6 months improves low-level auditory processing: Pilot study

Retsa, C., Knebel, J., Geiser, E., Ferrari, C., Jenni, R., Fournier, M., Alameda, L., Baumann, P., Clarke, S., Conus, P., et al. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.07.008 · Cited by 40 · see citing works

Timely N-Acetyl-Cysteine and Environmental Enrichment Rescue Oxidative Stress-Induced Parvalbumin Interneuron Impairments via MMP9/RAGE Pathway: A Translational Approach for Early Intervention in Psychosis

Dwir, D., Cabungcal, J.-H., Xin, L., Giangreco, B., Parietti, E., Cleusix, M., Jenni, R., Klauser, P., Conus, P., Cuénod, M., et al. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab066 · Cited by 40 · see citing works

Characterization of cerebral glucose dynamics in vivo with a four‐state conformational model of transport at the blood–brain barrier

Duarte, J. M. N., & Rolf Gruetter, A. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07688.x · Cited by 40 · see citing works

Redox and Immune Signaling in Schizophrenia: New Therapeutic Potential

Dwir, D., Khadimallah, I., Xin, L., Rahman, M., Du, F., Öngür, D., & Kim, Q. (2023) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyad012 · Cited by 40 · see citing works

Perineuronal nets as regulators of parvalbumin interneuron function: Factors implicated in their formation and degradation

Santos‐Silva, T., Colodete, D. A. E., Lisboa, J. R., Freitas, I. D. S., Lopes, C. F. B., Hadera, V., Lima, T. S. A., Souza, A. J., & Gomes, F. V. (2024) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13994 · Cited by 36 · see citing works

Taurine and N -acetylcysteine treatments prevent memory impairment and metabolite profile alterations in the hippocampus of high-fat diet-fed female mice

García-Serrano, A. M., Vieira, J. P. P., Fleischhart, V., & Duarte, J. M. N. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2022.2131062 · Cited by 36 · see citing works

Repositioning drugs for traumatic brain injury - N-acetyl cysteine and Phenserine

Hoffer, B. J., Pick, C. G., Hoffer, M. E., Becker, R. E., Chiang, Y. H., & Greig, N. H. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0377-1 · Cited by 35 · see citing works

Targeting Glia with N-Acetylcysteine Modulates Brain Glutamate and Behaviors Relevant to Neurodevelopmental Disorders in C57BL/6J Mice

Durieux, A. M. S., Fernandes, C., Murphy, D., Labouesse, M. A., Giovanoli, S., Meyer, U., Li, Q., So, P., & McAlonan, G. M. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00343 · Cited by 34 · see citing works

Large-scale animal model study uncovers altered brain pH and lactate levels as a transdiagnostic endophenotype of neuropsychiatric disorders involving cognitive impairment

Hagihara, H., Shoji, H., Hattori, S., Sala, G., Takamiya, Y., Tanaka, M., Ihara, M., Shibutani, M., Hatada, I., Hori, K., et al. (2024) · eLife · doi:10.7554/elife.89376.3 · Cited by 33 · see citing works

Gender and estrous cycle influences on behavioral and neurochemical alterations in adult rats neonatally administered ketamine

Borella, V., Seeman, M. V., Cordeiro, R. C., Santos, J. V. D., de Souza, M. R. M., Fernandes, E. N. D. S., Monte, A. S., Vasconcelos, S. M. M., Quinn, J. P., de Lucena, D. F., et al. (2015) · Developmental Neurobiology · doi:10.1002/dneu.22329 · Cited by 31 · see citing works

N-Acetylcysteine for the Treatment of Glutathione Deficiency and Oxidative Stress in Schizophrenia

Shungu, D. C. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.025 · Cited by 31 · see citing works

The potential of 1H-MRS in CNS drug development

Egerton, A. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05344-7 · Cited by 30 · see citing works

A practical guide to in vivo proton magnetic resonance spectroscopy at high magnetic fields

Xin, L., & Tkáč, I. (2016) · Analytical Biochemistry · doi:10.1016/j.ab.2016.10.019 · Cited by 28 · see citing works

Preclinical 1 H-Mrs Neurochemical Profiling in Neurological And Psychiatric Disorders

Lee, M. R., Đenić, A., Hinton, D. J., Mishra, P. K., Choi, D., Pirko, I., Rodriguez, M., & Macura, S. I. (2012) · Bioanalysis · doi:10.4155/bio.12.129 · Cited by 27 · see citing works

Anti-neuroinflammatory and antioxidant effects of N-acetyl cysteine in long-term consumption of artificial sweetener aspartame in the rat cerebral cortex

Saleh, A. A. S. (2015) · The Journal of Basic and Applied Zoology · doi:10.1016/j.jobaz.2015.05.001 · Cited by 26 · see citing works

Effects of acute N-acetylcysteine challenge on cortical glutathione and glutamate in schizophrenia: A pilot in vivo proton magnetic resonance spectroscopy study

Girgis, R. R., Baker, S. C., Mao, X., Gil, R. B., Javitt, D. C., Kantrowitz, J. T., Gu, M., Spielman, D. M., Ojeil, N., Xu, X., et al. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.03.018 · Cited by 26 · see citing works

The neuroprotective effects of N-acetylcysteine in psychiatric and neurodegenerative disorders: From modulation of glutamatergic transmission to restoration of synaptic plasticity

Chakraborty, S., Rao, S., & Tripathi, S. J. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110527 · Cited by 24 · see citing works

Developmental oxidative stress leads to T-type Ca2+ channel hypofunction in thalamic reticular nucleus of mouse models pertinent to schizophrenia

Khoueiry, C. E., Cabungcal, J.-H., Rovó, Z., Fournier, M., Kim, Q., & Steullet, P. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01425-2 · Cited by 22 · see citing works

Lactate: a prospective target for therapeutic intervention in psychiatric disease

Cai, Y., Guo, H., Han, T., & Wang, H. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.387969 · Cited by 21 · see citing works

Mountain-Cultivated Ginseng Attenuates Phencyclidine-Induced Abnormal Behaviors in Mice by Positive Modulation of Glutathione in the Prefrontal Cortex of Mice

Tran, T.-V., Shin, E., Ko, S. K., Nam, Y., Chung, Y. H., Jeong, J. H., Jang, C., Nah, S.-Y., Yamada, K., Nabeshima, T., et al. (2016) · Journal of Medicinal Food · doi:10.1089/jmf.2016.3751 · Cited by 21 · see citing works

The PPAR α Agonist Fenofibrate Reduces Prepulse Inhibition Disruption in a Neurodevelopmental Model of Schizophrenia

Rolland, B., Marche, K., Cottencin, O., & Bordet, R. (2012) · Schizophrenia Research and Treatment · doi:10.1155/2012/839853 · Cited by 20 · see citing works

Circadian Disruption Reveals a Correlation of an Oxidative GSH/GSSG Redox Shift with Learning and Impaired Memory in an Alzheimer’s Disease Mouse Model

LeVault, K. R., Tischkau, S. A., & Brewer, G. J. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150026 · Cited by 20 · see citing works

N-Acetylcysteine Mitigates Social Dysfunction in a Rat Model of Autism Normalizing Glutathione Imbalance and the Altered Expression of Genes Related to Synaptic Function in Specific Brain Areas

Schiavi, S., Rosa, P. L., Petrillo, S., Carbone, E., D’Amico, J., Piemonte, F., & Trezza, V. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.851679 · Cited by 18 · see citing works

Alterations in TRN-anterodorsal thalamocortical circuits affect sleep architecture and homeostatic processes in oxidative stress vulnerable Gclm−/− mice

Czekus, C., Steullet, P., López, A. O., Bozic, I., Rusterholz, T., Bandarabadi, M., Kim, Q., & Herrera, C. G. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01700-w · Cited by 17 · see citing works

Large-scale animal model study uncovers altered brain pH and lactate levels as a transdiagnostic endophenotype of neuropsychiatric disorders involving cognitive impairment

Hagihara, H., Shoji, H., Hattori, S., Sala, G., Takamiya, Y., Tanaka, M., Ihara, M., Shibutani, M., Hatada, I., Hori, K., et al. (2023) · eLife · doi:10.7554/elife.89376 · Cited by 50 · see citing works

Adolescent Stress-Induced Ventral Hippocampus Redox Dysregulation Underlies Behavioral Deficits and Excitatory/Inhibitory Imbalance Related to Schizophrenia

Santos‐Silva, T., Lopes, C. F. B., Ülgen, D. H., Guimarães, D. A., Guimarães, F. S., Alberici, L. C., Sandi, C., & Gomes, F. V. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae033 · Cited by 19 · see citing works

N-acetylcysteine prevents increased amphetamine sensitivity in social isolation-reared mice

Herrmann, A. P., Benvenutti, R., Pilz, L. K., & Elisabetsky, E. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.03.012 · Cited by 18 · see citing works

Social isolation stress and chronic glutathione deficiency have a common effect on the glutamine‐to‐glutamate ratio and myo‐inositol concentration in the mouse frontal cortex

Corcoba, A., Rolf Gruetter, A., Kim, Q., & Duarte, J. M. N. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14116 · Cited by 17 · see citing works

Oxidation and ubiquitination in neurodegeneration

Riederer, B. M., Leuba, G., & ElHajj, Z. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213488484 · Cited by 16 · see citing works

Reduction in phencyclidine induced sensorimotor gating deficits in the rat following increased system xc − activity in the medial prefrontal cortex

Lutgen, V., Qualmann, K. J., Resch, J. M., Kong, L., Choi, S., & Baker, D. L. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2926-3 · Cited by 16 · see citing works

Ferroptosis in schizophrenia: Mechanisms and therapeutic potentials (Review)

Lv, S., & Luo, C. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13402 · Cited by 14 · see citing works

Striatal Glutathione in First-episode Psychosis Patients Measured In Vivo with Proton Magnetic Resonance Spectroscopy

Reyes-Madrigal, F., León-Ortíz, P., Mao, X., Mora-Durán, R., Shungu, D. C., & de la Fuente‐Sandoval, C. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.08.003 · Cited by 14 · see citing works

Single spin-echo T 2 relaxation times of cerebral metabolites at 14.1 T in the in vivo rat brain

Xin, L., Gambarota, G., Cudalbu, C., Mlynárik, V., & Rolf Gruetter, A. (2013) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-013-0378-3 · Cited by 14 · see citing works

Acute Restraint-Mediated Increases in Glutamate Levels in the Rat Brain: An In Vivo 1H-MRS Study at 4.7 T

Kim, S.-Y., Jang, E.-J., Hong, K. S., Lee, C., Lee, D., Choi, C., Lee, H.-S., & Choe, B. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0668-y · Cited by 14 · see citing works

Progress in The Research of Lactate Metabolism Disruption And Astrocyte‐Neuron Lactate Shuttle Impairment in Schizophrenia: A Comprehensive Review

Zhang, Y., Tong, L., Ma, L., Ye, H., Zeng, S., Zhang, S., Ding, Y., Wang, W., & Bao, T. (2024) · Advanced Biology · doi:10.1002/adbi.202300409 · Cited by 13 · see citing works

Simultaneous detection of glutathione and lactate using spectral editing at 3 T

Chan, K. L., Snoussi, K., Edden, R. A. E., & Barker, P. B. (2017) · NMR in Biomedicine · doi:10.1002/nbm.3800 · Cited by 13 · see citing works

Neutrophil/lymphocyte ratio and cognitive performances in first-episode patients with schizophrenia and healthy controls

Liang, J., Guan, X., Sun, Q., Hao, Y., & Xiu, M. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111092 · Cited by 11 · see citing works

BEHAVIORAL AND BIOCHEMICAL EFFECTS OF CANNABIS SATIVA AND THEIR MODULATION BY ANTIDEPRESSANT DRUGS

Abdel‐Salam, O. M. E., Abdel-Rahman, R. F., & Gaafar, A. E.-D. M. (2013) · Revista latinoamericana de química · Cited by 11 · see citing works

Oxidative Stress in the Early Stage of Psychosis

Ventriglio, A., Bellomo, A., Favale, D., Bonfitto, I., Vitrani, G., Dario, D. S., Cuozzo, E., Ilaria, D. G., Pettorruso, M., Perna, G., et al. (2021) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026621666210701105839 · Cited by 11 · see citing works

Stable solid dispersion of lurasidone hydrochloride with augmented physicochemical properties for the treatment of schizophrenia and bipolar disorder

Pardhi, V. P., & Flora, S. J. S. (2020) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2252 · Cited by 12 · see citing works

Chronic N-Acetylcysteine Treatment Prevents Amphetamine-Induced Hyperactivity in Heterozygous Disc1 Mutant Mice, a Putative Prodromal Schizophrenia Animal Model

Lai, C., Baskaran, R., Tsao, C.-Y., Tuan, L., Siow, P.-F., Palani, M., Lee, L. J., Liu, C., Hwu, H., & Lee, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169419 · Cited by 9 · see citing works

Metabolic Insights into Neuropsychiatric Illnesses and Ketogenic Therapies: A Transcriptomic View

Sahay, S., Pulvender, P., Reddy, M. V. S. R. R., McCullumsmith, R. E., & O'Donovan, S. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158266 · Cited by 10 · see citing works

Developmental changes in cerebral NAD and neuroenergetics of an antioxidant compromised mouse model of schizophrenia

Skupienski, R., Steullet, P., Kim, Q., & Xin, L. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02568-2 · Cited by 10 · see citing works

The use of antioxidant compounds in the treatment of first psychotic episode: Highlights from preclinical studies

Schiavone, S., & Trabace, L. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12847 · Cited by 10 · see citing works

Biochemical effects of venlafaxine on astrocytes as revealed by 1H NMR-based metabolic profiling

Sun, L., Fang, L., Lian, B., Xia, J.-J., Zhou, C., Wang, L., Mao, Q., Wang, X., Gong, X., Liang, Z., et al. (2016) · Molecular BioSystems · doi:10.1039/c6mb00651e · Cited by 10 · see citing works

Chronic N-acetylcysteine treatment improves anhedonia and cognition in a mouse model of the schizophrenia prodrome

Bühner, L. M., Kapanaiah, S. K. T., & Kätzel, D. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.1002223 · Cited by 9 · see citing works

N-acetylcysteine facilitates extinction of cued fear memory in rats via reestablishing basolateral amygdala glutathione homeostasis

Wu, P., Guan, X., Wang, F., & Chen, J. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00661-0 · Cited by 11 · see citing works

Role of Oxidative Stress in Pathophysiological Progression of Schizophrenia

Bhatt, S., Upadhyay, T., Patil, C., Pai, K. S. R., Chellappan, D. K., & Dua, K. (2022) · Current Psychiatry Research and Reviews · doi:10.2174/2666082218666220822154558 · Cited by 8 · see citing works

Free-choice high-fat diet alters circadian oscillation of energy intake in adolescent mice: role of prefrontal cortex

Rio, D. D., Stucchi, P., Hernández-Nuño, F., Cano, V., Morales, L., Chowen, J. A., Olmo, N. D., & Ruiz‐Gayo, M. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1225-x · Cited by 8 · see citing works

Methodology of MRS in Animal Models: Technical Challenges and Solutions

Tkáč, I. (2016) · Contemporary clinical neuroscience · doi:10.1007/978-3-319-33555-1_2 · Cited by 8 · see citing works

Large-scale animal model study uncovers altered brain pH and lactate levels as a transdiagnostic endophenotype of neuropsychiatric disorders involving cognitive impairmentPreprint

Hagihara, H., Shoji, H., Hattori, S., Sala, G., Takamiya, Y., Tanaka, M., Ihara, M., Shibutani, M., Hatada, I., Hori, K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.02.428362 · Cited by 8 · see citing works

Progress in anti-ageing drug research for age-related diseases: A review

Zhou, Z., Duan, H.-T., Xue, S.-T., & Li, Z. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102982 · Cited by 7 · see citing works

N-Acetylcysteine Supplementation in an Individual With Glucose-6-Phosphate Dehydrogenase Deficiency–Associated Psychosis

Monsivais, S. R., Wisdom, N. M., Kruse, J. L., & Davis, M. C. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.02.028 · Cited by 7 · see citing works

METABOLIC ALTERATIONS IN THE CORTEX OF A MOUSE MODEL WITH GLUTATHIONE DEFICIT – RELEVANCE TO SCHIZOPHRENIA

Duarte, J. M. N., Kulak, A., Rolf Gruetter, A., & Kim, Q. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.271

A Developmental In Vivo 1 H Nmr Study In Mice With Genetic Redox Dysregulation: An Animal Model With Relevance To Schizophrenia

Frank, A., Duarte, J. M. N., Kim, Q., & Rolf Gruetter, A. (2009) · Infoscience (Ecole Polytechnique Fédérale de Lausanne) · doi:10.1111/j.1471-4159.2009.06239.x

Mice with chronic GSH deficit display phenotypical anomalies that resemble key aspects of schizophrenia

Kulak, A. (2011) · IRIS

N-Acetylcysteine for the Treatment of Glutathione Deficiency and Oxidative Stress in Schizophrenia

Shungu, D. C. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.025 · Cited by 31 · see citing works

Poster #16 ALTERATION OF SEVERAL SCHIZOPHRENIA CANDIDATE GENES EXPRESSION IN MEDIAL PREFRONTAL CORTEX IN PERINATAL ASPHYXIA RODENTMODEL

Wakuda, T., Iwata, K., Suzuki, K., Takei, N., & Mori, N. (2012) · Schizophrenia Research · doi:10.1016/s0920-9964(12)70849-6